期刊
PEDIATRIC SURGERY INTERNATIONAL
卷 29, 期 5, 页码 479-488出版社
SPRINGER
DOI: 10.1007/s00383-013-3267-y
关键词
Dermal substitutes; Matriderm; Tissue engineering; Split-thickness skin; Dermis; Epidermis; Skin reconstruction
资金
- EU-FP6 project EuroSTEC [LSHB-CT-2006-037409]
- EU-FP7 project EuroSkinGraft [279024]
- University of Zurich
- Fondation Gaydoul
- Dona Tissue
Currently, acellular dermal substitutes used for skin reconstruction are usually covered with split-thickness skin grafts. The goal of this study was to develop an animal model in which such dermal substitutes can be tested under standardized conditions using a bioengineered dermo-epidermal skin graft for coverage. Bioengineered grafts consisting of collagen type I hydrogels with incorporated human fibroblasts and human keratinocytes seeded on these gels were produced. Two different dermal substitutes, namely Matriderm(A (R)), and an acellular collagen type I hydrogel, were applied onto full-thickness skin wounds created on the back of immuno-incompetent rats. As control, no dermal substitute was used. As coverage for the dermal substitutes either the bioengineered grafts were used, or, as controls, human split-thickness skin or neonatal rat epidermis were used. Grafts were excised 21 days post-transplantation. Histology and immunofluorescence was performed to investigate survival, epidermis formation, and vascularization of the grafts. The bioengineered grafts survived on all tested dermal substitutes. Epidermis formation and vascularization were comparable to the controls. We could successfully use human bioengineered grafts to test different dermal substitutes. This novel model can be used to investigate newly designed dermal substitutes in detail and in a standardized way.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据